Purpose: GI motility disorders, including gastroparesis, chronic constipation, functional dyspepsia, and esophageal motility disorders, represent a significant and often underdiagnosed segment of digestive healthcare. Growing awareness, improved diagnostic tools, and expanding therapeutic options have positioned motility disorders as an important commercial market.
Upload here: https://gastroenterology-hepatology.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com
Keynote Points:
Rising adoption of diet-based management for chronic GI disorders
Strong market for medical foods, enteral nutrition, and specialized supplements
Growth of personalized nutrition and diet-planning platforms
Increasing role of dietitians and multidisciplinary GI care teams
Expansion into pediatric, geriatric, and oncology nutrition segments
Opportunities for clinical validation and science-backed product claims
Collaboration potential with gastroenterologists, hospitals, and wellness brands
Benefits:
Recurring revenue through long-term nutritional therapy and supplementation
High patient adherence and engagement with diet-based solutions
Strong brand credibility through clinical and dietary expertise
Cross-selling opportunities with diagnostics, therapeutics, and wellness products
Scalable business models via digital nutrition and subscription services
Alignment with preventive, patient-centric, and value-based healthcare